An open-label, pilot trial of adjunctive tocilizumab in schizophrenia

J Clin Psychiatry. 2016 Feb;77(2):275-6. doi: 10.4088/JCP.15l09920.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / pharmacology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pilot Projects
  • Receptors, Interleukin-6 / immunology*
  • Schizophrenia / drug therapy*
  • Schizophrenia / immunology*
  • Treatment Outcome
  • Young Adult

Substances

  • Antibodies, Monoclonal, Humanized
  • Receptors, Interleukin-6
  • tocilizumab